PTPRC and lymphoma: The biodistribution of CD45-binding mAbs was initially studied in 52 patients with different hematological malignancies (AML, MDS, MM and lymphoma) by injecting the Indium-111 [111In]-labelled mAb BC8 to follow its biodistribution and calculate the internal radiation doses (22).